Header cover image

Hong Kong Pharmaceuticals & Biotech Small Cap High Growth Stocks

UPDATED Jul 23, 2022

Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.

12 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
2552Hua Medicine (Shanghai)HK$3.989.9%-11.4%HK$3.8bHK$9.54PS508.7xE90.8%n/a
1061Essex Bio-TechnologyHK$3.740.3%-50.9%HK$2.1bHK$7.00PE6.2xE21.1%2.9%
1672Ascletis PharmaHK$3.521.4%8.6%HK$3.8bHK$2.37PS42.8xE97.3%n/a
1681Consun Pharmaceutical GroupHK$4.186.9%-13.6%HK$3.3bHK$9.00PE4.8xE10.3%6.8%
2142HBM HoldingsHK$3.540.6%-62.2%HK$2.6bHK$8.02PS76.2xE6.1%n/a
6998Genor Biopharma HoldingsHK$3.581.4%-77.8%HK$1.8bHK$5.02PB0.6xE6.3%n/a
6622Zhaoke OphthalmologyHK$3.551.4%-63.0%HK$1.9bHK$9.68PB0.7xE55.3%n/a
2126JW (Cayman) TherapeuticsHK$7.19-1.9%-68.3%HK$3.0bHK$16.69PS82.6xE10.1%n/a
6996AntengeneHK$5.50-3.5%-67.5%HK$3.6bHK$11.56PS109xE30.2%n/a
2256Abbisko CaymanHK$4.102.0%n/aHK$2.9bHK$7.87PS109.1xE32.6%n/a
1228CANbridge PharmaceuticalsHK$3.68-1.3%n/aHK$1.6bHK$12.37PS43.1xE17.0%n/a
6628Transcenta HoldingHK$4.11-6.2%n/aHK$1.8bHK$10.60PS31.3xE31.7%n/a
Page 1 of 1